1. Home
  2. MDBH vs PASG Comparison

MDBH vs PASG Comparison

Compare MDBH & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MDB Capital Holdings LLC common

MDBH

MDB Capital Holdings LLC common

N/A

Current Price

$1.66

Market Cap

18.3M

Sector

N/A

ML Signal

N/A

Logo Passage Bio Inc.

PASG

Passage Bio Inc.

N/A

Current Price

$3.55

Market Cap

14.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MDBH
PASG
Founded
1997
2017
Country
United States
United States
Employees
N/A
27
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.3M
14.6M
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
MDBH
PASG
Price
$1.66
$3.55
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $15.50
AVG Volume (30 Days)
4.5K
★ 13.3K
Earning Date
11-16-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$4.06
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.31
$3.29
52 Week High
$4.16
$20.00

Technical Indicators

Market Signals
Indicator
MDBH
PASG
Relative Strength Index (RSI) 36.25 39.14
Support Level N/A $3.29
Resistance Level $3.17 $5.03
Average True Range (ATR) 0.10 0.24
MACD 0.01 0.02
Stochastic Oscillator 46.62 23.83

Price Performance

Historical Comparison
MDBH
PASG

About MDBH MDB Capital Holdings LLC common

MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The company operates in two reportable segments: a broker dealer & intellectual property service; and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.

About PASG Passage Bio Inc.

Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.

Share on Social Networks: